BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37341602)

  • 21. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
    Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
    Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MET is overexpressed in microsatellite instability-high gastric carcinoma.
    Sim J; Heo YJ; Bae H; Shin HC; Kim B; Cho J; Kim ST; Lee J; Kang WK; Kim KM
    Pathol Res Pract; 2019 Mar; 215(3):433-438. PubMed ID: 30455128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
    Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
    Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
    Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
    Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
    Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
    Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PD-L1 expression in EBV-associated gastric carcinomas].
    Danilova NV; Sotnikova TN; Kalinin DV; Oleynikova NA; Chayka AV; Khomyakov VM; Kakotkin VV; Vychuzhanin DV; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(4):5-12. PubMed ID: 35880594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
    Kawazoe A; Shitara K; Kuboki Y; Bando H; Kojima T; Yoshino T; Ohtsu A; Ochiai A; Togashi Y; Nishikawa H; Doi T; Kuwata T
    Gastric Cancer; 2019 Jan; 22(1):69-76. PubMed ID: 29859006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.
    Kim DH; Bae GE; Suh KS; Ryuman D; Song KS; Kim JS; Lee SI; Yeo MK
    In Vivo; 2020; 34(6):3171-3180. PubMed ID: 33144421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
    Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
    Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated PD-L1 Expression and Microsatellite Instability in Elderly Patients With Gastric Cancer.
    Chen TH; Chen MH; Hung YP; Chiang NJ; Huang KH; Lin YH; Lin RW; Chao Y; Li AF; Yu HY; Hwang HE; Yeh YC; Wang YC; Fang WL
    J Immunother; 2023 Apr; 46(3):111-119. PubMed ID: 36809276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis.
    Ma SM; Dong J; Liang L; Liu XT; Meng XY; Zhang HS; Yang J
    Eur J Surg Oncol; 2022 Jan; 48(1):211-217. PubMed ID: 34483031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
    Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
    Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
    Setia N; Ahn S; Han HS; Park DY; Lauwers GY
    Hum Pathol; 2019 Dec; 94():64-70. PubMed ID: 31676362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.
    Kim TS; da Silva E; Coit DG; Tang LH
    Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features.
    Hissong E; Ramrattan G; Zhang P; Zhou XK; Young G; Klimstra DS; Shia J; Fernandes H; Yantiss RK
    Am J Surg Pathol; 2018 Apr; 42(4):453-462. PubMed ID: 29438172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 Expression in colorectal carcinoma and its correlation with clinicopathological parameters, microsatellite instability and BRAF mutation.
    Srivastava P; Husain N; Shukla S; Chauhan S; Pandey A; Masood S
    Indian J Pathol Microbiol; 2021; 64(3):490-496. PubMed ID: 34341259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression level and prognostic value of PD-L1 in microsatellite instability-high gastric cancer].
    Wang XY; Hu YJ; Dong K; Zhao C; Huang XZ; Lian SY; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1114-1119. PubMed ID: 33152814
    [No Abstract]   [Full Text] [Related]  

  • 40. PD-L1 Antibodies for EBV-Positive Gastric Cancer, Going Beyond PD-L1 Expression and Microsatellite Instability.
    Almhanna K; Antonia S
    J Natl Cancer Inst; 2018 Mar; 110(3):221-222. PubMed ID: 29155933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.